Skip to main content
. 2022 Sep 5;39(1):77–84. doi: 10.1007/s12288-022-01562-w

Table 3.

Adverse Events

RfCHOP arm (N = 28) RCHOP arm (N = 27)
Grade I-II Grade III-V Grade I-II Grade III-V
Anemia 15 (53.5%) 7 (25%) 8 (29.6%) 6 (22.2%)
Neutropenia 7 (25%) 17 (60.7%) 8 (29.6%) 14 (51.9%)
Febrile Neutropenia - 9 (32.1%) - 4 (14.8%)
Thrombocytopenia 10 (35.7%) 2 (7.1%) 11 (40.7%) 0
Diarrhoea 6 (21.4%) 1 (3.6%) 2 (7.4%) 2 (7.4%)
Constipation 4 (14.3%) 1 (3.6%) 7 (25.9%) 1 (3.7%)
Vomiting 6 (21.4%) - 8 (29.6%) -
Neuropathy 10 (35.7%) 1 (3.6%) 8 (29.6%) -